During the past decade, Specialized clinical Infectious diseases Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Specialized clinical Infectious diseases Hospital" are "Chronic Hepatitis Delta" (2 trials) and "Influenza" (1 trials). Many other conditions were trialed in "Specialized clinical Infectious diseases Hospital" in a lesser frequency.

Most popular intervention types in "Specialized clinical Infectious diseases Hospital" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bulevirtide" (2 trials), "AV5080" (1 trials), "Peginterferon Alfa-2a (PEG-IFN alfa)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Specialized clinical Infectious diseases Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Specialized clinical Infectious diseases Hospital". 1 are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Specialized clinical Infectious diseases Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Specialized clinical Infectious diseases Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".